Oramed grants Scilex option to repurchase Penny Warrants for up to $27M; clarifies warrant terms

ORAMED PHARMACEUTICALS INC.

Scilex pays $1.5M option fee in two installments ($750K by Aug 8, 2025; $750K by Dec 16, 2025).
Scilex may repurchase 3.13M warrants for $13M by Sep 30, 2025, and 3.37M warrants for $14M by Dec 31, 2025.
If all payments made, Tranche A Note maturity extends to Mar 31, 2026, and make-whole payment waived.
Oramed clarifies Penny Warrant exercise price remains $0.01/share post 1-for-35 reverse split, not $0.35.
Correction has no impact on financial position, results, or cash flows as of Mar 31, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.